Back
Travere Therapeutics Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
38
TVTX
Travere Therapeutics
Last Price:
18.7700
Seasonality Move:
13.52%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Travere Therapeutics Price Quote
$18.7700
-0.2600 (-1.37%)
(Updated: November 12, 2024 at 5:55 PM ET)
Travere Therapeutics Key Stats
Sell
38
Travere Therapeutics (TVTX)
is a Sell
Day range:
$18.9950 - $20.3300
52-week range:
$5.1200 - $20.3300
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.22
P/B ratio:
0%
Volume:
1.3M
Avg. volume:
2M
1-year change:
241.04%
Market cap:
$1.5B
Revenue:
$145.2M
EPS:
$-4.55
How Much Does Travere Therapeutics Make?
-
How Much Are Travere Therapeutics's Sales Annually?
TVTX Revenues are $145.2M -
How Much Profit Does Travere Therapeutics's Make A Year?
TVTX net income is -$111.4M
Is Travere Therapeutics Growing As A Company?
-
What Is Travere Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.7% -
What Is Travere Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Travere Therapeutics Stock Price Performance
-
Did Travere Therapeutics Stock Go Up Last Month?
Travere Therapeutics share price went up by 15.97% last month -
Did TVTX's Share Price Rise Over The Last Year?
TVTX share price rose by 241.04% over the past 1 year
What Is Travere Therapeutics 52-Week High & Low?
-
What Is Travere Therapeutics’s 52-Week High Share Price?
Travere Therapeutics has traded as high as $20.3300 over the past 52 weeks -
What Is Travere Therapeutics’s 52-Week Low Share Price?
Travere Therapeutics has traded as low as $5.1200 over the past 52 weeks
Travere Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Travere Therapeutics?
-
How Much Debt Does Travere Therapeutics Have?
Total long term debt quarterly is $378.6M -
How Much Cash Does Travere Therapeutics Have?
Cash and short term investments quarterly total is $277.4M -
What Is Travere Therapeutics’s Book Value Per Share?
Book value per share is -0.39
Is Travere Therapeutics Cash Flow Positive?
-
What Is TVTX Cash Flow From Operations?
Cash flow from operations (TTM) is -$272.2M -
What Is Travere Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $427K -
What Is Travere Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $162.7M
Travere Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TVTX return on invested capital is -72.38% -
What Is Travere Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -52.6% -
What Is TVTX Return On Equity?
ROE is a measure of profitability and is -325.82%
Travere Therapeutics Earnings Date & Stock Price
-
What Is Travere Therapeutics's Stock Price Today?
A single share of TVTX can be purchased today for 19.0300 -
What Is Travere Therapeutics’s Stock Symbol?
Travere Therapeutics trades on the nasdaq under the ticker symbol: TVTX -
When Is Travere Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Travere Therapeutics is scheduled on February 14, 2025 -
When Is TVTX's next ex-dividend date?
Travere Therapeutics's next ex-dividend date is November 13, 2024 -
How To Buy Travere Therapeutics Stock?
You can buy Travere Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Travere Therapeutics Competitors
-
Who Are Travere Therapeutics's Competitors?
Below is a list of companies who compete with Travere Therapeutics or are related in some way:
Travere Therapeutics Dividend Yield
-
What Is TVTX Dividend Yield?
Travere Therapeutics’s dividend yield currently is 0% -
What Is Travere Therapeutics’s Payout Ratio?
Travere Therapeutics’s payout ratio is 0% -
When Did Travere Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Travere Therapeutics’s Dividend Per Share?
Travere Therapeutics pays a dividend of $0.0000 per share
Travere Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 14.26% |
| Revenue: | 69.56% | 3.4% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 26.3750 |
| Upside from Last Price: | 38.6% |